Foxp3-specific ablation of upstream mTORC1 activators, RagA/B and Rheb, severely impair Treg suppressive function leading not only to uncontrolled systemic inflammation, but also enhanced anti-tumor immunity (147–149). This evidence concerns the gene FOXP3 and neoplasm.